Back

Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials

Cardiovascular Research

7 August 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Arjen J Cupido
Arjen J Cupido

Author

John J P Kastelein
John J P Kastelein

Author

You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials
30 August 2021
thumbnail
Webinar
New trial evidence in the field of lipid management
19 April 2024
thumbnail
Congress Session
New frontiers in heart failure therapies
19 May 2025
thumbnail
Congress Presentation
Value of sustained LDL-C lowering: learnings from long-term data
1 September 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources